share_log

東陽光長江藥業:根據《收購守則》規則22作出的交易披露

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

香港交易所 ·  Mar 12 05:30
Summary by Moomoo AI
東陽光長江藥業(HEC CJ PHARM)於2024年3月12日公布,其私有化交易已經完成。根據香港《公司收購及合併守則》規則22,CICC Financial Trading Limited於2024年3月11日為自身帳戶清結了兩宗衍生工具合約,涉及總數3,169,600股份。第一宗合約以每股9.3294美元的價格,總金額為14,785,231.50美元;第二宗合約則以每股9.3351美元成交,總金額為14,794,340.68美元。交易後,CICC Financial Trading Limited持有的東陽光長江藥業股份數量為零。CICC Financial Trading Limited為要約人的關聯公司,並獲豁免自營買賣商資格。
東陽光長江藥業(HEC CJ PHARM)於2024年3月12日公布,其私有化交易已經完成。根據香港《公司收購及合併守則》規則22,CICC Financial Trading Limited於2024年3月11日為自身帳戶清結了兩宗衍生工具合約,涉及總數3,169,600股份。第一宗合約以每股9.3294美元的價格,總金額為14,785,231.50美元;第二宗合約則以每股9.3351美元成交,總金額為14,794,340.68美元。交易後,CICC Financial Trading Limited持有的東陽光長江藥業股份數量為零。CICC Financial Trading Limited為要約人的關聯公司,並獲豁免自營買賣商資格。
DONG SUNSHINE CHANGJIANG PHARMACEUTICALS (HEC CJ PHARM) ANNOUNCED ON MARCH 12, 2024 THAT ITS PRIVATIZATION TRANSACTION HAS BEEN COMPLETED. In accordance with Rule 22 of the Hong Kong Code of Acquisitions and Mergers, CICC Financial Trading Limited settled two derivative contracts on its own account on 11 March 2024, involving a total of 3,169,600 shares. The first contract was priced at $9.3294 per share for a total amount of $14,785,231.50; the second contract was traded at $9.3351 per share for a total amount of $14,794,340.68. After the transaction, the number of shares of Dongsun Changjiang Pharmaceutical Company held by CICC Financial Trading Limited is zero. CICC Financial Trading Limited is an associate company of the offeror and is exempt from the status of a self-employed trader.
DONG SUNSHINE CHANGJIANG PHARMACEUTICALS (HEC CJ PHARM) ANNOUNCED ON MARCH 12, 2024 THAT ITS PRIVATIZATION TRANSACTION HAS BEEN COMPLETED. In accordance with Rule 22 of the Hong Kong Code of Acquisitions and Mergers, CICC Financial Trading Limited settled two derivative contracts on its own account on 11 March 2024, involving a total of 3,169,600 shares. The first contract was priced at $9.3294 per share for a total amount of $14,785,231.50; the second contract was traded at $9.3351 per share for a total amount of $14,794,340.68. After the transaction, the number of shares of Dongsun Changjiang Pharmaceutical Company held by CICC Financial Trading Limited is zero. CICC Financial Trading Limited is an associate company of the offeror and is exempt from the status of a self-employed trader.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more